Beyond HGPS, given the beneficial effects of Ang2 in protecting against insulin resistance and diet-induced weight gain, Ang2 treatment may offer new therapeutic options for the treatment of obesity and metabolic disorders. This evidence concerns the gene ANGPT2 and Insulin resistance.